JF
ABVX

Jump Financial’s Abivax ABVX Stock Holding History

Jump Financial’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$723K Buy
+5,424
New +$614K 0.01% 1320
2026
Q1 		– Sell
-6,463
Closed -$872K – 1824
2025
Q4 		$872K Buy
+6,463
New +$705K 0.01% 1036

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jump Financial's ABVX Position: Q2 2026 in Review

Jump Financial opened a new position in Abivax (ABVX) in Q2 2026: 5,424 shares worth $723K. The stake represents 0.01% of the portfolio and ranks #1320 among its holdings. This is a return to the name: Jump Financial previously reported a position in ABVX as recently as Q4 2025.

Jump Financial first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $872K in Q4 2025. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Jump Financial held 5,424 shares of Abivax worth $723K as of Q2 2026.
  • Abivax was a new Jump Financial position in Q2 2026.
  • Abivax made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1320 holding.
  • Jump Financial first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Jump Financial's Abivax position peaked at $872K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.